Min‐Hsien Wang

473 total citations
21 papers, 378 citations indexed

About

Min‐Hsien Wang is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Min‐Hsien Wang has authored 21 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Min‐Hsien Wang's work include Diabetes Treatment and Management (8 papers), Peptidase Inhibition and Analysis (5 papers) and Neuropeptides and Animal Physiology (5 papers). Min‐Hsien Wang is often cited by papers focused on Diabetes Treatment and Management (8 papers), Peptidase Inhibition and Analysis (5 papers) and Neuropeptides and Animal Physiology (5 papers). Min‐Hsien Wang collaborates with scholars based in Taiwan and United States. Min‐Hsien Wang's co-authors include Hsien‐Te Peng, Chiung‐Tong Chen, Ching‐Fang Yu, Teng‐Kuang Yeh, Jen‐Shin Song, Yu‐Sheng Chao, Szu‐Huei Wu, Chun‐Hsu Yao, Jinq‐Chyi Lee and Kai‐Chia Yeh and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Life Sciences.

In The Last Decade

Min‐Hsien Wang

20 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min‐Hsien Wang Taiwan 13 114 110 97 95 62 21 378
Dandan Huang China 11 47 0.4× 52 0.5× 146 1.5× 59 0.6× 33 0.5× 17 328
Ned B. Smith United States 9 16 0.1× 40 0.4× 95 1.0× 31 0.3× 63 1.0× 12 347
Ziye Liu China 9 8 0.1× 74 0.7× 139 1.4× 14 0.1× 16 0.3× 19 333
Donald Sarubbi United States 9 22 0.2× 44 0.4× 141 1.5× 19 0.2× 63 1.0× 17 370
Tatsuyuki Naruchi Japan 10 45 0.4× 55 0.5× 104 1.1× 40 0.4× 46 0.7× 40 381
Wei Ren China 12 11 0.1× 13 0.1× 229 2.4× 115 1.2× 43 0.7× 50 504
Ki Chul Park South Korea 13 64 0.6× 4 0.0× 113 1.2× 30 0.3× 36 0.6× 37 460
Yuanyuan Kuang China 10 11 0.1× 13 0.1× 125 1.3× 19 0.2× 19 0.3× 26 278
M. Arnold Switzerland 7 71 0.6× 29 0.3× 141 1.5× 6 0.1× 91 1.5× 7 362
Allen Schmidt United States 12 274 2.4× 30 0.3× 222 2.3× 4 0.0× 270 4.4× 15 548

Countries citing papers authored by Min‐Hsien Wang

Since Specialization
Citations

This map shows the geographic impact of Min‐Hsien Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Hsien Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Hsien Wang more than expected).

Fields of papers citing papers by Min‐Hsien Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min‐Hsien Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Hsien Wang. The network helps show where Min‐Hsien Wang may publish in the future.

Co-authorship network of co-authors of Min‐Hsien Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Min‐Hsien Wang. A scholar is included among the top collaborators of Min‐Hsien Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min‐Hsien Wang. Min‐Hsien Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Weisheng, Hui‐Yi Lin, Hao Chan, et al.. (2023). Postfermented Tea Extract Potently Alleviates Glucose Metabolism Disorders In Vitro and In Vivo. ACS Food Science & Technology. 4(2). 479–490.
2.
Yeh, Kai‐Chia, Teng‐Kuang Yeh, Min‐Hsien Wang, et al.. (2021). DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity. Life Sciences. 278. 119574–119574. 10 indexed citations
3.
Wang, Min‐Hsien, et al.. (2021). The acute effects of whole body vibration stimulus warm-up on skill-related physical capabilities in volleyball players. Scientific Reports. 11(1). 5606–5606. 15 indexed citations
4.
Chen, Yunyu, Chen‐Fu Lo, Chia‐Yu Hsu, et al.. (2020). BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy. Translational Oncology. 14(1). 100897–100897. 15 indexed citations
5.
Chen, Yen‐Ju, Teng‐Kuang Yeh, Min‐Hsien Wang, et al.. (2020). Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System. Scientific Reports. 10(1). 2838–2838. 7 indexed citations
6.
7.
Peng, Hsien‐Te, Chen‐Yi Song, Brian Wallace, et al.. (2019). Effects of Relative Drop Heights of Drop Jump Biomechanics in Male Volleyball Players. International Journal of Sports Medicine. 40(13). 863–870. 19 indexed citations
8.
Song, Jen‐Shin, Chiung‐Tong Chen, Teng‐Kuang Yeh, et al.. (2018). Synthesis and biological evaluation of N-glucosyl indole derivatives as sodium-dependent glucose co-transporter 2 inhibitors. Bioorganic Chemistry. 83. 520–525. 12 indexed citations
9.
Yeh, Teng‐Kuang, Chiung‐Tong Chen, Jen‐Shin Song, et al.. (2017). Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2. European Journal of Medicinal Chemistry. 143. 611–620. 13 indexed citations
10.
Wang, Min‐Hsien, et al.. (2017). Can Different Complex Training Improve the Individual Phenomenon of Post-Activation Potentiation?. Journal of Human Kinetics. 56(1). 167–175. 28 indexed citations
11.
Yao, Chun‐Hsu, Jen‐Shin Song, Chiung‐Tong Chen, et al.. (2016). N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors. Bioorganic & Medicinal Chemistry. 24(10). 2242–2250. 20 indexed citations
12.
Lin, Wen-Yang, et al.. (2015). Rough-set-based ADR signaling from spontaneous reporting data with missing values. Journal of Biomedical Informatics. 58. 235–246. 5 indexed citations
13.
Yao, Chun‐Hsu, Jen‐Shin Song, Chiung‐Tong Chen, et al.. (2012). Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors. European Journal of Medicinal Chemistry. 55. 32–38. 41 indexed citations
14.
Peng, Hsien‐Te, et al.. (2012). The Acute Effect of Drop Jump Protocols With Different Volumes and Recovery Time on Countermovement Jump Performance. The Journal of Strength and Conditioning Research. 27(1). 154–158. 48 indexed citations
15.
Yeh, Teng‐Kuang, Tsu Hsu, Jai‐Hong Cheng, et al.. (2010). (2S,4S)-1-[2-(1,1-Dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV. Bioorganic & Medicinal Chemistry Letters. 20(12). 3596–3600. 15 indexed citations
16.
Yao, Chun‐Hsu, Jen‐Shin Song, Chiung‐Tong Chen, et al.. (2010). Discovery of Novel N-β-d-Xylosylindole Derivatives as Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for the Management of Hyperglycemia in Diabetes. Journal of Medicinal Chemistry. 54(1). 166–178. 44 indexed citations
17.
Hsu, Tsu, Chiung‐Tong Chen, Jai‐Hong Cheng, et al.. (2009). (1,3‐Diphenyl‐1H‐Pyrazol‐4‐yl)‐Methylamine Analogues as Inhibitors of Dipeptidyl Peptidases. Journal of the Chinese Chemical Society. 56(5). 1048–1055. 7 indexed citations
18.
Hsu, Tsu, Chiung‐Tong Chen, Jai‐Hong Cheng, et al.. (2009). Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(7). 1908–1912. 22 indexed citations
19.
Hsu, Tsu, Chiung‐Tong Chen, Jai‐Hong Cheng, et al.. (2009). Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry. 17(6). 2388–2399. 15 indexed citations
20.
Yang, Yun-Liang, Chih‐Wei Wang, Chiung‐Tong Chen, et al.. (2008). Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells. Mycological Research. 113(3). 388–390. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dandan Huang Breakdown of academic impact, for papers by Ned B. Smith Breakdown of academic impact, for papers by Ziye Liu Breakdown of academic impact, for papers by Donald Sarubbi Breakdown of academic impact, for papers by Tatsuyuki Naruchi Breakdown of academic impact, for papers by Wei Ren Breakdown of academic impact, for papers by Ki Chul Park Breakdown of academic impact, for papers by Yuanyuan Kuang Breakdown of academic impact, for papers by M. Arnold Breakdown of academic impact, for papers by Allen Schmidt
Rankless by CCL
2026